Glycated LDL as a marker of erectile dysfunction severity in diabetes: evidence for a role of metabolic memory

Authors:

Abstract
Erectile dysfunction (ED) is a common complication of type 2 diabetes mellitus and is closely linked to endothelial dysfunction and metabolic disturbances. However, the relationship between glycemic control and ED severity remains inconsistent, suggesting that cumulative metabolic injury may play a more important role. In this cross-sectional comparative study, 60 diabetic patients with ED and 60 age-matched healthy controls were evaluated. ED severity was assessed using the International Index of Erectile Function-5 (IIEF-5), and patients were stratified according to ED severity and glycemic control (HbA1c <7% vs. ≥7%). Circulating glycated low-density lipoprotein (g-LDL) levels were significantly higher in patients with ED compared to controls (p < 0.001) and increased progressively with ED severity (η² = 0.39). In multivariable analysis, g-LDL (OR = 1.014, p = 0.003) and duration of diabetes (OR = 1.041, p = 0.008) were identified as independent predictors of ED severity, whereas HbA1c was not. Despite significant differences in HbA1c between controlled and uncontrolled diabetic groups (p = 0.009), no differences were observed in g-LDL levels or erectile function scores, while strong group effects were observed for g-LDL (η² = 0.76) and IIEF (η² = 0.80). These findings indicate that g-LDL is strongly associated with ED severity and may reflect cumulative metabolic injury more effectively than HbA1c, supporting the concept that long-term metabolic burden contributes to the pathogenesis of diabetic ED in line with mechanisms related to metabolic memory.